Moderna falls as social media posts flag potential cancer vaccine data leak
MRNA•Moderna shares fell 24% to $187.40 after social media posts flagged a potential leak of late-stage data from its cancer vaccine trial with Merck. Detailed trial data is due at the ESMO Congress on October 24.
1. Shares fall on posts
Several posts on Reddit and X noted a potential leak of late-stage data from a cancer vaccine developed by Moderna and Merck. Moderna shares fell 24% to $187.40.
2. Data due October 24
Detailed data from the Moderna-Merck cancer vaccine trial is due at the ESMO Congress on October 24. Earlier this month, Moderna joined the Nasdaq 100 index, replacing Warner Bros Discovery.
3. Analyst ratings
Six of 25 brokerages rate Moderna shares “buy” or higher, 15 rate them “hold” and four rate them “sell” or lower. Their median price target is $130.
